Pinki Bhatt is an Infectious Disease physician affiliated with Rutgers. OpenAlex indexes 19 publications with 358 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Robert Wood Johnson Pl
New Brunswick, NJ 089011928
Telephone
732-235-7708Provider last certified this registry record 18 Apr 2022.
Clinical trials
- One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
Sponsor: Rutgers, The State University of New Jersey
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
- Astellas Pharma US IncProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor43.5%Triumeq100%Part D<11 patientsAzole Antifungal32.3%Voriconazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P-132. Retrospective Comparison of Short and Prolonged Treatment Strategies for Patients with Neutropenic Enterocolitis
Open Forum Infectious Diseases
2025 - Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship
Open Forum Infectious Diseases
2025 - P-2279. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia on Anti-Fungal Prophylaxis (2022)
Open Forum Infectious Diseases
2025 - Effectiveness of piperacillin/tazobactam loading dose for extended infusion dosing among patients with Gram-negative bacteraemia
Journal of Antimicrobial Chemotherapy
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Sherine Gabriel, MD
Rutgers
Julius Gardin, MD
Rutgers
Abraham Aviv, MD
Rutgers
Partho Sengupta, MD, DM
Rutgers
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”